We are live on ! Find out more
NVO

Novo Nordisk
NVO

1,350 hedge funds and large institutions have $15.6B invested in Novo Nordisk in 2026 Q2 according to their latest regulatory filings, with 215 funds opening new positions, 464 increasing their positions, 459 reducing their positions, and 117 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 215 | Existing positions closed: 117

27% more funds holding in top 10

Funds holding in top 10: 11 → 14 (+3)

26% more capital invested

Capital invested by funds: $12.4B → $15.6B (+$3.26B)

6% more funds holding

Funds holding: 1,277 → 1,350 (+73)

1% more repeat investments, than reductions

Existing positions increased: 464 | Existing positions reduced: 459

0.01% more ownership

Funds ownership: 9.62% → 9.62% (+0.01%)

9% less call options, than puts

Call options by funds: $2.35B | Put options by funds: $2.58B

Holders
1,350
Holders Change
+73
Holders Change %
+5.72%
% of All Funds
16.31%
Holding in Top 10
14
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+27.27%
% of All Funds
0.17%
New
215
Increased
464
Reduced
459
Closed
117
Calls
$2.35B
Puts
$2.58B
Net Calls
-$225M
Net Calls Change
+$475M

Top Buyers

Rank Fund Capital Flow
1
FAM
Fred Alger Management
New York
+$211M
2
Goldman Sachs
Goldman Sachs
New York
+$174M
3
Bank of Nova Scotia
Bank of Nova Scotia
Ontario, Canada
+$129M
4
Nuveen
Nuveen
North Carolina
+$128M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$98.2M

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$270M
2
Two Sigma Investments
Two Sigma Investments
New York
-$269M
3
Franklin Resources
Franklin Resources
California
-$131M
4
Capital International Investors
Capital International Investors
California
-$89.1M
5
Jane Street
Jane Street
New York
-$87M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$145M -$15.7M -364,700 -11%
Nuveen
27
Nuveen
North Carolina
$142M +$128M +2,969,256 New
Fayez Sarofim & Co
28
Fayez Sarofim & Co
Texas
$140M -$20.2M -470,979 -14%
Raymond James Financial
29
Raymond James Financial
Florida
$139M -$26.9M -627,017 -18%
MG
30
Markel Group
Virginia
$138M – – –
Barclays
31
Barclays
United Kingdom
$131M -$23.4M -544,019 -17%
Acadian Asset Management
32
Acadian Asset Management
Massachusetts
$131M +$98.2M +2,286,233 +508%
FCM
33
Farallon Capital Management
California
$126M +$78.9M +1,837,000 +235%
Fidelity Investments
34
Fidelity Investments
Massachusetts
$111M +$41M +953,773 +71%
Millennium Management
35
Millennium Management
New York
$97.6M +$26.9M +627,086 +45%
Natixis Advisors
36
Natixis Advisors
Massachusetts
$96.2M +$28.6M +666,676 +50%
LPL Financial
37
LPL Financial
California
$83.3M +$17.8M +414,404 +31%
Marshall Wace
38
Marshall Wace
United Kingdom
$81.8M -$57.6M -1,339,507 -44%
Ameriprise
39
Ameriprise
Minnesota
$80.6M -$2.53M -58,781 -3%
CCM
40
Causeway Capital Management
California
$80.4M +$21.6M +503,402 +43%
MC
41
Maverick Capital
Texas
$79.3M -$18.3M -426,249 -20%
JP Morgan Chase
42
JP Morgan Chase
New York
$77.9M -$51.4M -1,196,392 -43%
Rockefeller Capital Management
43
Rockefeller Capital Management
New York
$75.1M +$5.73M +133,378 +9%
Stifel Financial
44
Stifel Financial
Missouri
$71.7M +$14.6M +339,036 +29%
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$71.5M +$38.8M +903,306 +153%
American Century Companies
46
American Century Companies
Missouri
$69.8M +$10.5M +244,032 +20%
Citadel Advisors
47
Citadel Advisors
Florida
$65.5M -$58.9M -1,370,250 -50%
Dimensional Fund Advisors
48
Dimensional Fund Advisors
Texas
$62M +$1.8M +41,840 +3%
SEI Investments
49
SEI Investments
Pennsylvania
$59.9M +$32.8M +762,636 +157%
TI
50
Trexquant Investment
Connecticut
$58.8M +$10.5M +244,632 +25%
1
2
3 4 5

NVO Hedge Fund Activity: Q2 2026 in Review

1,350 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q2 2026, worth a combined $15.6B — up 26% from $12.4B a quarter earlier.

Buyers outnumbered sellers: 215 funds opened new NVO positions and 117 closed out — a net gain of 98 holders — while 464 added to existing stakes and 459 trimmed.

The largest buyer was Fred Alger Management, opening a new position worth an estimated $211M. The largest seller was Susquehanna International Group, cutting an estimated $270M.

  • 1,350 institutional investors held Novo Nordisk (NVO) as of Q2 2026, up from 1,277 in Q1 2026.
  • Funds reported $15.6B of Novo Nordisk stock for Q2 2026, up 26% quarter-over-quarter.
  • 215 funds opened new Novo Nordisk positions in Q2 2026 and 117 closed out, a net change of +98 holders.
  • The largest Novo Nordisk buyer in Q2 2026 was Fred Alger Management, an estimated $211M added.
  • The largest Novo Nordisk seller in Q2 2026 was Susquehanna International Group, an estimated $270M sold.

Based on aggregated 13F filings for Q2 2026.